Back Source: > 01 December 2009 (E-Business) Aeolus Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile--Aarkstore Enterprise New report "Aeolus Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile" available through Aarkstore.com  Aeolus Pharmaceuticals Inc. (Aeolus), a biopharmaceutical company, is engaged in the development of new class of catalytic antioxidant compounds. These compounds are used for disease and disorders of the central nervous system, respiratory system, autoimmune system and oncology. The company has developed 200 proprietary catalytic antioxidant compounds from its inception. It is focusing on the side effects of mustard gas exposure, cancer radiation therapy and amyotrophic lateral sclerosis. The lead product candidate of the company is AEOL 10150. In March 2009, the company raised $1.5 million for further development of AEOL 10150. The company is headquartered in California, the US Aeolus Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company’s major recent financial deals. Scope - Provides key company information for business intelligence needs - Gives information on the company’s major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships. - Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement. For more information please visit : http://www.aarkstore.com/reports/Aeolus-Pharmaceuticals-Inc-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-20187.html  Visit